info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)

Rising Prevalence of Respiratory Disorders and Wide Acceptance of Inhaler Devices Has Enhanced the Growth of Global Asthma Devices Market

Pune, India, January, 2021/MRFR Press Release/- Market Research Future published a Half - Cooked research report on “Global Asthma Devices Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.


Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd., Baxter, Boehringer Ingelheim GmbH, Koninklijke Philips N.V., and others are some of the prominent players at the forefront of competition in the Global Asthma Devices Market and are profiled in MRFR Analysis. 


Global Asthma Devices Market - Overview


The global asthma devices market is growing moderately. Rising prevalence of chronic respiratory disease and increasing usage of combination therapy are the major factor driving the asthma devices market.


The Asthma Devices Market is anticipated to reach USD 7202.6 Million by 2030 at 4.7% CAGR during the forecast period 2022-2030.


The global asthma devices market has been evaluated as steadily growing market and expected that the market will reach high growth figures. Respiratory inhalers, and nebulizers are the devices which are used to control the respiratory conditions by directly inhaling the drug into the respiratory tract. Over the past 50 years, inhaler devices have revolutionized the respiratory care by delivering the medicines directly into the lungs and avoiding the adverse effects caused by the other modes of medication. However there has been a point of concern for the doctors whether the patients are talking the medication correctly or not. Because, even if you have the most potent drug in the inhaler; if the patient does not take the medication correctly and on time, you will not see the desired effect of the drug. Different inhaler drugs are being developed for the different conditions and the inhalers are prescribed to the patients on the basis of the condition of the patient and the severity of the disease. There are some major factors that are driving the market growth such as rising prevalence of respiratory disorders due to increase pollution and unhealthy lifestyle, increasing usage of combination therapies due to associated benefits such as more reliable in complex patients, increased efficacy and easy reimbursement policies associated with them and others.


On the other hand, there are some hindering factors which are restricting the market growth such as side effects and complications during inhalation, high prices of devices, and lack of accuracy etc. The market is expected to show large opportunities in the coming future with the advancement of technology in developing countries and new products with increased accuracy. However, some of the challenges which the market is expected to face includes competition from new entrants or big pharmaceutical giants entering the business or market and the continuous advancements in the product.


Industry Updates


Feb, 2017 BI received expantion of FDA approval of the use of Tiotropium Respimat for treatment of Asthma in Children. With this approval, company will be able to sell the product inside the United States.


Jan, 2017 AstraZeneca announced that on 25 January 2017 the US Food and Drug Administration (FDA) granted six months of paediatric exclusivity for Symbicort (budesonide/formoterol) Inhalation Aerosol. Symbicort is approved in the US to treat asthma in patients 12 years and older and for the maintenance and treatment of COPD in adults, the company is expecting larger market share with the product launch.


Nov, 2016 Chiesi acquires Atopix therapeutics. The acquisition of the UK based clinical stage biotechnology company will help Chiesi enhance its Asthma Segment.


Feb, 2015 AstraZeneca and Actavis Plc have entered into a definitive agreement under which AstraZeneca will acquire the rights to Actavis’ branded respiratory business in the U.S. and Canada for an initial consideration of $600 million on completion and low single-digit royalties above certain revenue threshold.


Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Asthma Devices Market Research Report


Global Asthma Devices Market -


Regional Analysis


Depending on geographic region, Globally North America is the largest market for Asthma Inhalers. Currently there are around 6.4% of American suffering from COPD in U.S. and around 5.4 million people suffering from asthma in U.K. This major growth is attributed to the popularity of the dry powder inhalers among population due to its several advantages over Metered Dose Inhalers and other types of inhalers.


Europe is the second-largest market for asthma inhalers.  It is observed that almost 70% of the child’s death occurred per year due to respiratory disorders are due to these sudden attacks hence rescue medication or rescue inhalers can serve better to save lots of lives per year.


Asia pacific region is expected to be fastest growing region in respiratory Inhaler market. Middle East & Africa is expected to have limited but steady growth in the market. These countries with the advancement of technology are expected to show large number of cases of asthma and other respiratory disease which remain unnoticed currently.


 


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Report details
Base Year 2021
Companies Covered 15
Pages 90
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.